CORRECTING and REPLACING Remicade(R) (Infliximab) Receives Positive Opinion ... MarketWatch (press release) ... in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies. |
